Qube Research & Technologies (QRT)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-72,143
Closed -$4.5M 3971
2025
Q3
$4.5M Buy
+72,143
New +$5.02M ﹤0.01% 1815
2025
Q2
Sell
-17,527
Closed -$1.51M 3866
2025
Q1
$1.51M Sell
17,527
-73,573
-81% -$6.03M ﹤0.01% 2090
2024
Q4
$7.11M Sell
91,100
-13,502
-13% -$1.05M 0.01% 1304
2024
Q3
$7.54M Buy
104,602
+65,958
+171% +$4.67M 0.01% 1199
2024
Q2
$2.66M Buy
38,644
+22,951
+146% +$1.55M ﹤0.01% 1505
2024
Q1
$1.14M Sell
15,693
-56,556
-78% -$3.78M ﹤0.01% 2068
2023
Q4
$4.42M Buy
72,249
+157
+0.2% +$9.32K 0.01% 1112
2023
Q3
$4.12M Buy
72,092
+34,430
+91% +$2.08M 0.01% 1025
2023
Q2
$2.24M Buy
+37,662
New +$2.25M 0.01% 1003
2022
Q4
Sell
-22,914
Closed -$1.14M 2864
2022
Q3
$1.14M Buy
22,914
+4,757
+26% +$263K 0.01% 1153
2022
Q2
$1.07M Sell
18,157
-24,065
-57% -$1.33M 0.01% 1079
2022
Q1
$2.23M Buy
42,222
+22,084
+110% +$1.28M 0.02% 777
2021
Q4
$1.22M Buy
20,138
+8,145
+68% +$484K 0.01% 1072
2021
Q3
$673K Buy
+11,993
New +$659K 0.01% 1070
2020
Q3
Sell
-26,842
Closed -$1.01M 2004
2020
Q2
$1.01M Buy
+26,842
New +$1.07M 0.01% 859
2018
Q4
Sell
-1,983
Closed -$75K 728
2018
Q3
$75K Buy
1,983
+1,865
+1,581% +$70.5K 0.01% 825
2018
Q2
$5K Buy
+118
New +$3.98K ﹤0.01% 799

Other funds holding PBH

Qube Research & Technologies (QRT)'s PBH Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 72,143 shares — an estimated $4.5M sold.

Qube Research & Technologies (QRT) first reported a position in PBH in Q2 2018 and held it in 17 quarters. The position peaked at $7.54M in Q3 2024. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 72,143 Prestige Consumer Healthcare shares in Q4 2025, an estimated $4.5M.
  • Qube Research & Technologies (QRT) first reported a position in Prestige Consumer Healthcare in Q2 2018 and held it in 17 quarters.
  • Qube Research & Technologies (QRT)'s Prestige Consumer Healthcare position peaked at $7.54M in Q3 2024.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.